May 15, 1995

                                        Eingegangen
                                            29.MAI 1995
To: Mr. Sherwin Gardner, Chairman
From: J.L. Charles, Secretary

Subject: Meeting Notes for the Philip Morris USA Scientific Advisory Board Meeting,
May 11, 1995

The third meeting of the Philip Morris USA Scientific Advisory Board was held at the
Park Hyatt hotel in Washington, D.C. on May 11, 1995. Present were Mr. Sherwin
Gardner (Chairman), Dr. Joseph Borzelleca, Dr. Yoshio lharafa, Dr. William Hall, Dr.
Bert La Du Jr., Dr. Robert Libby and Dr. James Charles (Secretary).

1. The final Laboratory Inspection Report for CRC and INBI FO by Drs. Hall and Libby
was approved.

2. There were no further concerns with nickel analyses.

3. Information on aluminum concentrations in tobacco and smoke as well as TLV data
was requested. Dr. Carchman agreed to provide this information for the Board.

4. Regarding the 21-day inhalation study planned for August, 1995:

    A. Heater geometry and thermal characteristics should be as close as possible to
       that which will be used in the 90-day inhalation study.

    B. Individual Board members will be present on Day 7 for chemistry; Day 21 and 22
       for necropsy. There will be a review of the histopathology as well as a GLP review when
       the final report is available. A roster of what Board members will be present on what
       days will be provided.

5. There will be a short Board meeting at the Park Hyatt in Washington, D.C. on July
10, 1995. Sandwiches will be available at 12 noon on that date.

6. There will be a full Board meeting at INBI FO to review the 21-day inhalation results
as soon as the histopathology results are available (probably late October).

7. The protocol for the planned 90-day inhalation study (January, 1996 start date) will be
finalized and approved at the October Board meeting.

Respectfully submitted,
William H. Chase

8999305668